Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
Clinical trial NCT02537158 · UNKNOWN
Trial details
- NCT number
- NCT02537158
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.